A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data (B7451085) First published 29/11/2024 Last updated 07/01/2025 EU PAS number:EUPAS1000000345 Study Ongoing